Kenya Cardiovascular Diseases Therapeutics Market Analysis

Kenya Cardiovascular Diseases Therapeutics Market Analysis


$ 3999

Kenya's cardiovascular disease therapeutics market is projected to grow from $114 Mn in 2022 to $216 Mn in 2030 with a CAGR of 8.32% for the year 2022-30. The rise in prevalence of the cardiovascular diseases in Kenya and the increasing awareness about different therapeutic options in Kenya are the major growth drivers of the market. The Kenya cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Kenton, Jaskam, and Lupin are the major players in the Kenya cardiovascular disease therapeutics market.

ID: IN10KEPH033 CATEGORY: Pharmaceuticals GEOGRAPHY: Kenya AUTHOR: Dr. Parul Choudhary

Buy Now

Kenya Cardiovascular Disease Therapeutics Market Executive Analysis

Kenya's cardiovascular disease therapeutics market is projected to grow from $114 Mn in 2022 to $216 Mn in 2030 with a CAGR of 8.32% for the year 2022-30. In the 2022–23 fiscal year, $1.27 Bn will be allocated to the healthcare industry in Kenya, of which $540 Mn will go towards Universal Health Coverage (UHC). The estimated cost of the 2022–23 budget is $29 Bn, which is $3.03 Bn less than the estimated cost of the 2021/22 fiscal year, which was $32 Bn, of which the health sector got $1.05 Bn.

In Kenya, hypertension is now the most prevalent cardiovascular condition, affecting more than 20 Mn individuals, according to estimates. Hypertensive end-organ damage is a significant cause of morbidity and death in Kenya. Statins are drugs that lower cholesterol and lower the chance of heart attack and stroke. In Kenya, atorvastatin and simvastatin are two common statins. In addition to lowering blood pressure, beta-blockers lower the chance of heart attack and stroke. Metoprolol and atenolol are two beta-blockers that are frequently used in Kenya. Blood pressure is lowered by using ACE inhibitors, which also lower the chance of heart attack and stroke. Lisinopril and enalapril are two ACE inhibitors that are frequently prescribed in Kenya.  Blood pressure is lowered by calcium channel blockers, which also lower the chance of heart attack and stroke. Amlodipine and nifedipine are two calcium channel blockers that are frequently used in Kenya. Blood pressure is lowered and excess bodily fluid is reduced by the use of diuretics. In Kenya, diuretics like furosemide and hydrochlorothiazide are frequently prescribed.  The possibility of blood clots and stroke is decreased by the antiplatelet drug aspirin. Patients with a history of cardiovascular disease are frequently provided with it. A drug called nitroglycerin is used to address angina, which is chest pain brought on by inadequate heart blood flow. It increases blood flow by relaxing blood arteries.

Kenya Cardiovascular Disease Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

The Kenya cardiovascular disease therapeutics market is being driven by a steady rise in the prevalence of cardiovascular diseases in Kenya in recent years. Changing lifestyles are related to the increase in frequency.  The population of Kenya is becoming more conscious of the dangers and effects of cardiovascular diseases. In Kenya, the market for therapeutics for cardiovascular disease is expanding as a result of technological advancements. For instance, it is anticipated that in the upcoming years, there will be a rise in the use of mobile health technology to monitor and manage cardiovascular disease.

Market Restraints

Kenya's healthcare system is underdeveloped which may restrict patient access to treatments for cardiovascular illness, which might in turn restrict the Kenya cardiovascular disease therapeutics market expansion. The cost of cardiovascular disease therapies may restrict entry for patients who cannot afford treatment. If the expense of the treatment is not covered by insurance or the government, this may slow market expansion.  Kenya suffers from a shortage of qualified healthcare workers, which may affect their capacity to identify and manage cardiovascular diseases. By lowering the number of patients who receive treatment, may slow market development.

Competitive Landscape

Key Players

  • Regal Pharmaceuticals (KEN)
  • Transwide Pharmaceuticals (KEN)
  • Biodeal Laboratories (KEN)
  • Kentons (KEN)
  • Jaskam (KEN)
  • Lupin
  • Silvergate Pharmaceuticals
  • TSH Biopharm
  • Novartis
  • Relypsa
  • Vectus Biosystems
  • Phasebio Pharmaceuticals
  • Ablative Solutions

Healthcare Policies and Regulatory Landscape

A government-run health insurance program called the National Hospital Insurance Fund (NHIF) covers both inpatient and outpatient treatments, including those for cardiovascular disease. Members of the program pay a monthly premium and have access to medical care at institutions that have earned NHIF accreditation. The government-sponsored Linda Mama Program offers free maternal and child health services, such as cardiovascular disease screening and therapy, to women who are expecting young children. Community Health Workers (CHWs) are educated people of the community who offer basic healthcare services, such as cardiovascular disease screening and management, in underserved regions of the nation. The CHW initiative is funded by the government to increase access to healthcare services. The Essential Medicines List (EML), established by the Kenyan government, contains drugs for cardiovascular disease. By doing this, patients are guaranteed access to and affordability of these medicines.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiovascular Disease Therapeutics Segmentation

By Disease Indication (Revenue, USD Billion):

  • Hypertension
  • Coronary Artery Disease
  • Hyperlipidaemia
  • Arrhythmia
  • Others

By Drug Type (Revenue, USD Billion):

  • Antihypertensive
  • Anticoagulants
  • Antihyperlipidemic
  • Antiplatelet Drugs
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By Drug Classification (Revenue, USD Billion):

  • Branded Drugs
  • Generic Drugs

By Mode of Purchase (Revenue, USD Billion):

  • Prescription-Based Drugs
  • Over-The-Counter Drugs

By End Users (Revenue, USD Billion):

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 23 June 2023
Updated by: Shivam Zalke

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up